Evidence map›Paper›PMID 41898309›Full record

ArticleBiomedicines2026

A Predictive Immunological Signature Associated with Pathological Response in Breast Cancer Treated with Neoadjuvant Chemotherapy.

Luis Arturo Palafox-Mariscal, Mariel García-Chagollán, Jesús García-Gómez, Fabiola Martín-Amaya-Barajas, Valeria Peña-Ruiz, Elizabeth Alvarez-Gonzalez, Eric Alfredo Aranda-Zuno, Jonathan Gallegos-Diaz-de-Leon, Aldo Antonio Alcaraz-Wong, Karina Ordoñez-Pantoja and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Luis Arturo Palafox-MariscalDivisión de Inmunología, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico.
Mariel García-ChagollánInstituto de Investigación en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
Jesús García-GómezPrograma de Doctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
Fabiola Martín-Amaya-BarajasPrograma de Maestría en Ciencias Médicas, Facultad de Medicina, Universidad de Colima, Colima 28040, Colima, Mexico.
Valeria Peña-RuizUnidad Médica de Alta Especialidad, Hospital de Ginecología y Obstetricia, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44349, Jalisco, Mexico.
Elizabeth Alvarez-GonzalezUnidad Médica de Alta Especialidad, Hospital de Ginecología y Obstetricia, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44349, Jalisco, Mexico.
Eric Alfredo Aranda-ZunoPrograma de Doctorado en Ciencias Biomédicas, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, Guadalajara 44340, Jalisco, Mexico.
Jonathan Gallegos-Diaz-de-LeonServicio de Patología, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44349, Jalisco, Mexico.
Aldo Antonio Alcaraz-WongServicio de Patología, Hospital de Especialidades, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44349, Jalisco, Mexico.
Karina Ordoñez-PantojaLaboratorio de Anatomía Patológica y Citologia, Hospital General Regional 110, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44716, Jalisco, Mexico.
Raquel Villegas-PachecoUnidad Médica de Alta Especialidad, Hospital de Ginecología y Obstetricia, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44349, Jalisco, Mexico.
Adriana Aguilar-LemarroyDivisión de Inmunología, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0001-9288-4824
Luis Felipe Jave-SuarezDivisión de Inmunología, Centro de Investigación Biomédica de Occidente (CIBO), Instituto Mexicano del Seguro Social (IMSS), Guadalajara 44340, Jalisco, Mexico.ORCID 0000-0001-6209-5031

Funding

Mexican Social Security Institute R-2023-1305 and R-2024-1305-077
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

breast cancerimmunological signatureneoadjuvant chemotherapypathological response

Identifiers

PMID41898309
PMCPMC13023440

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.